Navigation Links
Elsevier's Maturitas publishes position statement on fertility preservation
Date:11/6/2013

Amsterdam, November 6, 2013 Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) in the journal Maturitas on the topic of fertility preservation.

The rising need for fertility preservation results from two new 21st century changes. Improved survival of malignant disease with gonadotoxic treatments means that long-term reproductive potential should now be considered. Delaying childbirth means that the use of fertility preservation techniques to counter the normal age-related decline in fertility is also becoming a topic of interest for many healthy women.

This EMAS position paper provides and critically appraises evidence on available options for fertility preservation in both pre-pubertal and post-pubertal men and women. EMAS position paper recommends that all men and women of reproductive age should be thoroughly informed before the initiation of any gonadotoxic treatment about the possible risks of the treatment in question and all available options of fertility preservation should be discussed. Fertility preservation should be a priority when treating children or adults of reproductive age with agents that may have hazardous effects on the reproductive system and gonadotoxicity should be kept at a minimum.

These and other recommendations presented in the EMAS' position statement on fertility preservation are published in the article: "EMAS Position statement: Fertility preservation," published in Maturitas, Elsevier; available online on ScienceDirect.


'/>"/>

Contact: Greyling Peoples
g.peoples@elsevier.com
31-204-853-323
Elsevier
Source:Eurekalert

Page: 1

Related biology news :

1. Elseviers Maturitas publishes clinical guide on endometrial assessment in postmenopausal women
2. Genetics in Medicine publishes special issue dedicated to genomics in electronic health records
3. Journal of Spinal Cord Medicine publishes special issue on assistive technology
4. American Academy of Microbiology publishes West Nile virus report
5. Reproductive BioMedicine Online publishes study on assisted reproduction
6. Leading RSV researcher publishes work at Le Bonheur Childrens
7. PeerJ publishes its first articles
8. Mercury releases contaminate ocean fish: Dartmouth-led effort publishes major findings
9. Professor publishes on first-ever imaging of cells growing on spherical surfaces
10. NYBG press publishes final volume of landmark Intermountain Flora series
11. The ENCODE Project publishes new genomic insights in special issue of Genome Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute announced ... Larry Schlesinger as the Institute,s new President and ... effective May 31, 2017. He is currently the Chair of ... the Center for Microbial Interface Biology at Ohio State University. ... the new President and CEO of Texas Biomed," said Dr. ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent ... availability of a new report, Sensors for Robotics: Technologies, Markets ... ... ... IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  If only one ... had a mutation-conferring resistance to chemotherapy, thousands of ... research has focused on finding these mutations in ... from circulating tumor DNA in blood — to ... therapeutics. Unfortunately, however, detecting these genetic ...
(Date:2/16/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company ... better treatment for triple negative breast cancer (TNBC), announced today ... program. The YEi Start in ... help entrepreneurs grow their business in France ... companies selected to complete an intensive one week immersion in ...
(Date:2/16/2017)... LOS ANGELES , Feb. 16, 2017 /PRNewswire/ ... CAPR ), a clinical-stage biotechnology company developing first-in-class ... today announced that it has elected to terminate ... to natriuretic peptide receptor agonists, including Cenderitide. ... a strategic move as we prioritize our efforts ...
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
Breaking Biology Technology: